/Companies

Apeiron Therapeutics

Burlingame, US · 17 employees on LinkedIn · 2 known investors

Find your way into Apeiron Therapeutics

Sign up to see every warm intro you have to Apeiron Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Apeiron Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.

Founders & leadership

ML
Mingxi LiCEO
FAFred Aswad
Fred AswadChief Scientific OfficerFred Aswad is Chief Scientific Officer at Apeiron Therapeutics, a biotech firm developing small-molecule therapeutics for immuno-oncology and oncology. He brings 18 years of drug discovery experience spanning target identification through clinical development in cancer and immunology, with background in both small-molecule and biologic programs.

Investors · 2

In the news

Frequently asked questions

What does Apeiron Therapeutics do?
Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.
Who are Apeiron Therapeutics's investors?
Apeiron Therapeutics's investors include Sofinnova Ventures, Panacea Venture.
Where is Apeiron Therapeutics headquartered?
Apeiron Therapeutics is headquartered in Burlingame, US.